Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

Putting calcipotriol ointment on the skin once doesn't change calcium levels in the body right away.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

The treatment showed limited success in repigmenting hair for vitiligo-associated leukotrichia.

Combining cytostatic and steroid drugs effectively treats systemic lupus erythematosus.

Isotretinoin is a preferred treatment for severe acne, often leading to long-term improvement, but requires careful monitoring due to potential side effects.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

The updated criteria improve the accuracy of diagnosing lupus.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Adalimumab was safe but mostly ineffective for severe alopecia areata.

Delonix polymeric nanoparticles with isotretinoin effectively treat acne by targeting hair follicles and reducing skin irritation.

Combining a 675 nm laser with isotretinoin improves acne treatment results.

Leflunomide and methotrexate are equally effective for rheumatoid arthritis but have different side effects.

Monoclonal antibodies are often linked to alopecia areata cases.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

Cyperus rotundus essential oil effectively treats underarm darkening, reduces inflammation, and slows hair growth.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Antizyme slows skin tumor growth by reducing cell growth in mice.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Tofacitinib significantly improved skin and hair conditions without side effects.

The cream effectively reduced hair growth on forearms.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

More skin lesions in lupus patients may indicate higher disease activity.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.